Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merrimack Pharmaceuticals Inc
(NQ:
MACK
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merrimack Pharmaceuticals Inc
< Previous
1
2
Next >
Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday
November 09, 2022
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Upstart (UPST) Stock Sinks on Gloomy Forecast
November 09, 2022
Upstart (UPST) stock is sliding lower on Wednesday following a poor performance in the third quarter of 2022 and a weak outlook.
Via
InvestorPlace
Why Is Merrimack Pharmaceuticals (MACK) Stock Up 220% Today?
November 09, 2022
Merrimack Pharmaceuticals (MACK) stock is rocketing higher on Wednesday following positive Phase III clinical trial data.
Via
InvestorPlace
US Stocks Open Lower; Dow Drops 250 Points
November 09, 2022
U.S. stocks traded lower this morning as investors focused on the outcome of the midterm elections, with the Dow Jones dropping around 250 points on Wednesday.
Via
Benzinga
Why Merrimack Shares Are Surging Over 200% Today?
November 09, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 09, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 09, 2022
Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings...
Via
Benzinga
Merrimack Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Merrimack Pharmaceuticals, Inc.
Via
Business Wire
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
October 18, 2022
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 05, 2022
Wednesday saw 127 companies set new 52-week lows.
Via
Benzinga
Merrimack Reports Second Quarter 2022 Financial Results
August 04, 2022
From
Merrimack Pharmaceuticals, Inc.
Via
Business Wire
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 03, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 03, 2022
Via
Benzinga
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
August 03, 2022
Via
Benzinga
Merrimack Provides Ipsen Report of Results From Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer
August 03, 2022
From
Merrimack Pharmaceuticals, Inc.
Via
Business Wire
Merrimack Reports First Quarter 2022 Financial Results
May 05, 2022
From
Merrimack Pharmaceuticals, Inc.
Via
Business Wire
53 Biggest Movers From Yesterday
April 08, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
April 07, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price...
Via
Benzinga
50 Biggest Movers From Friday
February 07, 2022
Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 04, 2022
Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is...
Via
Benzinga
41 Biggest Movers From Yesterday
January 27, 2022
Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave...
Via
Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
January 26, 2022
Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 32% to $0.7262 after the company announced a share buyback of up to 100 million shares of common stock at $1 per share...
Via
Benzinga
3 Penny Stocks Insiders Are Buying
January 14, 2022
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...
Via
Benzinga
Merrimack Reports Third Quarter 2021 Financial Results
November 04, 2021
From
Merrimack Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
September 27, 2021
Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. Keros Therapeutics's stock is trading at a volume...
Via
Benzinga
Merrimack Reports Second Quarter 2021 Financial Results
August 05, 2021
From
Merrimack Pharmaceuticals, Inc.
Via
Business Wire
Elevation Oncology Files for $100M IPO
June 07, 2021
Elevation Oncology has filed to raise $100 million in an IPO. See SEC prospectus here. Proceeds will be used to support the development of seribantumab that failed...
Via
Benzinga
Topics
Initial Public Offering
Regulatory Compliance
Exposures
Legal
Regulatory
Securities Market
Last Week's Notable Insider Buys Included Evergy, StoneMor, Tattooed Chef And More
April 18, 2021
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Even with a new earnings season underway, insiders were...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.